Independent of the exact mechanism, our data suggest that inhibition of the QKI/SERPINA1 3’UTR interaction offers a potential therapeutic strategy for increasing A1AT expression in the lungs of individuals with COPD. This evidence concerns the gene QKI and chronic obstructive pulmonary disease.